Sana stock rose on positive results from single patient. CEO Steve Harr hails "incredibly important scientific finding" on insulin-producing cell implants.
UnitedHealth's CEO acknowledged discontent with the health care system, but quickly shifted the blame elsewhere.
A new crop of companies is lining up to buy patient data from hospitals and sell it to those wanting to train AI or do research.
Huntington's disease research has focused on toxic proteins tied to a mutant gene. New study suggests cause lies in growth of the gene itself
Cancer deaths overall are falling, but the breakdown of new cases is disturbing, the American Cancer Society reports.
Despite concern about their appeal to the young, Zyn nicotine pouches can help adults quit tobacco, FDA says.
STAT spoke with researcher Carol Haywood about her new study that looked at the persistent ableism in medicine and its root causes.
Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health care spending.
As the health care sector embraces AI, the incoming administration confronts some pressing challenges about what to regulate, and how.
